Your gateway to a free society
Article

The Duke Faculty and Administration Damaged the Intellectual Foundations of Higher Education

By opposing justice and throwing aside the facts of hard science, the Duke faculty and administration damaged all of higher education during the infamous lacrosse hoax.
Back

aboutLiberty Portal

Liberty Portal is your gateway for free markets and free thinking. We aggregate open-sourced content to promote and popularize important people and lessons within the liberty movement.
suggested
Feb 27, 2026 / Tyler Durden
Trump Orders Halt To 'Woke' Anthropic Technology Across All Federal Agencies
Trump Orders Halt To 'Woke' Anthropic Technology Across All Federal Agencies Update (1603ET): An hour before a 5PM ET deadline, President Donald Trump directed 'EVERY Federal Agency in the United States Government to IMMEDIATELY CEASE all use of Anthropic’s technology," posting on Truth Social that "We don't need it, we don't want it, and we will not do business with them again."  According to Trump: There will be a six month phase out period for agencies already using Anthropic products If Anthropic isn't 'helpful' during the transition, Trump will pursue civil and criminal charges Defense secretary Pete...
Read more
Jun 29, 2026 / Dave DeCamp
Trump Claims the US and Iran Will Hold Talks in Qatar After Exchange of Strikes
President Trump on Monday said that the US and Iran will hold negotiations in Doha, Qatar, on Tuesday despite the two sides trading strikes over the weekend, though an Iranian official denied that technical talks under the US-Iran Memorandum of Understanding (MoU) were scheduled. “IRAN HAS REQUESTED A MEETING. IT WILL TAKE PLACE TOMORROW IN […]
Read more
Aug 5, 2026 / Tyler Durden
"Momentum Continues": Lilly Jumps After Raising Revenue Outlook On Surging GLP-1 Demand
"Momentum Continues": Lilly Jumps After Raising Revenue Outlook On Surging GLP-1 Demand Shares of Eli Lilly & Co. are rising in premarket trading after the pharmaceutical giant raised its full-year revenue forecast following a 48% jump in second-quarter sales, fueled by accelerating demand for the diabetes drug Mounjaro and the obesity treatment Zepbound. Lilly's second-quarter results topped Wall Street expectations: Adjusted earnings rose to $8.38 a share from $6.31 a year earlier. Revenue surged 48% to $22.97 billion, beating the $20.59 billion Bloomberg Consensus estimate. Mounjaro generated $9.94 billion in sales, exceeding...
Read more

support

If you like what we do and want to support us, then you are a fine humanitarian. Click the link below to find out more.

Support the liberty movement